Guardian Wealth Advisors LLC Has $860,000 Stake in Cardinal Health, Inc. (NYSE:CAH)

Guardian Wealth Advisors LLC lowered its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 7,269 shares of the company’s stock after selling 244 shares during the period. Cardinal Health accounts for about 0.6% of Guardian Wealth Advisors LLC’s portfolio, making the stock its 23rd largest position. Guardian Wealth Advisors LLC’s holdings in Cardinal Health were worth $860,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp boosted its stake in shares of Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after purchasing an additional 627,253 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Pacer Advisors Inc. grew its stake in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after purchasing an additional 191,568 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Cardinal Health by 2.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after buying an additional 33,388 shares during the period. Finally, Two Sigma Advisers LP increased its stake in shares of Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock valued at $118,197,000 after acquiring an additional 346,362 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Down 0.3 %

Cardinal Health stock opened at $127.07 on Friday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The stock has a market cap of $30.70 billion, a P/E ratio of 23.71, a P/E/G ratio of 1.46 and a beta of 0.63. The company’s 50-day moving average price is $122.35 and its two-hundred day moving average price is $114.92.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts anticipate that Cardinal Health, Inc. will post 7.92 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. Cardinal Health’s dividend payout ratio is 37.69%.

Analyst Ratings Changes

Several research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday. Morgan Stanley raised their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Wells Fargo & Company lifted their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday. Barclays increased their price objective on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $136.87.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.